Latest Arthritis: Drugs news
FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases
posted October 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases
posted October 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pharmacovigilance Needed for Rheumatology Patients
posted September 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Recommendations have been developed for pharmacovigilance in rheumatology, emphasizing the need for continued monitoring of new drugs, according to a position statement issued by the American College of Rheumatology.
GLP-1 Receptor Agonists Tied to Increased Risk for Alopecia .jpg)
Health Consequences Vary by Chemo Regimen in Testicular Cancer Survivors 
Satisfaction With Semaglutide Driven by Effective Weight Loss 
Meta-Analysis Identifies Few Adverse Events Attributed to Statin Use Related Articles
87.5 Million U.S. Adults Now Eligible for Statins Under New Guidelines 
For Most People, Risk for Serious Muscle Disorders From Statins Is Low 
Oxybutynin Beats Placebo for Reducing ADT-Linked Hot Flashes in Prostate Cancer 
Sodium-Glucose Cotransporter 2 Inhibitors Tied to Lower Use of Gout Medications Monthly Specialist Briefings
Stay Connected
